VIR-7831 for the Early Treatment of COVID-19 in Outpatients
Public ClinicalTrials.gov record NCT04545060. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II/III Randomized, Multi-center, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Monoclonal Antibody VIR-7831 for the Early Treatment of Coronavirus Disease 2019 (COVID-19) in Non-hospitalized Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a phase 2/3 study in which subjects with coronavirus disease 2019 (COVID-19) will receive VIR-7831 or placebo and will be assessed for safety, tolerability, efficacy, and pharmacokinetics.
Study identification
- NCT ID
- NCT04545060
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 1,057 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 27, 2020 (Actual)
- Primary completion
- Apr 8, 2021 (Actual)
- Completion
- Sep 2, 2021 (Actual)
- Last update posted
- Nov 7, 2022
2020 – 2021
United States locations
- U.S. sites
- 63
- U.S. states
- 20
- U.S. cities
- 52
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigative Site | Anniston | Alabama | 36207 | — |
| Investigative Site | Cullman | Alabama | 35055 | — |
| Investigative Site | Mesa | Arizona | 85210 | — |
| Investigative Site | Tucson | Arizona | 85712 | — |
| Investigative Site | Los Angeles | California | 90017 | — |
| Investigative Site | Los Angeles | California | 90036 | — |
| Investigative Site | Northridge | California | 91325 | — |
| Investigative Site | Oxnard | California | 93030 | — |
| Investigative Site | Rolling Hills Estates | California | 90274 | — |
| Investigative Site | Sacramento | California | 95817 | — |
| Investigative Site | Doral | Florida | 33166 | — |
| Investigative Site | Gainesville | Florida | 32607 | — |
| Investigative Site | Hialeah | Florida | 33016 | — |
| Investigative Site | Miami | Florida | 33122 | — |
| Investigative Site | Miami | Florida | 33125 | — |
| Investigative Site | Miami | Florida | 33155 | — |
| Investigative Site | Miami | Florida | 33173 | — |
| Investigative Site | Miami | Florida | 33186 | — |
| Investigative Site | Miramar | Florida | 33027 | — |
| Investigative Site | North Miami | Florida | 33169 | — |
| Investigative Site | Palmetto Bay | Florida | 33157 | — |
| Investigative Site | Pembroke Pines | Florida | 33024 | — |
| Investigative Site | Pompano Beach | Florida | 33064 | — |
| Investigative Site | Tampa | Florida | 33614 | — |
| Investigative Site | Tampa | Florida | 33615 | — |
| Investigative Site | Atlanta | Georgia | 30315 | — |
| Investigative Site | Atlanta | Georgia | 30318 | — |
| Investigative Site | Decatur | Georgia | 30030 | — |
| Investigative Site | Stockbridge | Georgia | 30281 | — |
| Investigative Site | Idaho Falls | Idaho | 83404 | — |
| Investigative Site | Mishawaka | Indiana | 46544 | — |
| Investigative Site | Lake Charles | Louisiana | 70601 | — |
| Investigative Site | Marrero | Louisiana | 70072 | — |
| Investigative Site | Baltimore | Maryland | 21230 | — |
| Investigative Site | Caro | Michigan | 48723 | — |
| Investigative Site | Hazelwood | Missouri | 63042 | — |
| Investigative Site | Las Vegas | Nevada | 89109 | — |
| Investigative Site | Las Vegas | Nevada | 89130 | — |
| Investigative Site | Santa Fe | New Mexico | 87505 | — |
| Investigative Site | The Bronx | New York | 10456 | — |
| Investigative Site | Asheboro | North Carolina | 27203 | — |
| Investigative Site | Charlotte | North Carolina | 28208 | — |
| Investigative Site | Columbus | Ohio | 43215 | — |
| Investigative Site | Smithfield | Pennsylvania | 15478 | — |
| Investigative Site | Chattanooga | Tennessee | 37421 | — |
| Investigative Site | Austin | Texas | 78705 | — |
| Investigative Site | Baytown | Texas | 77521 | — |
| Investigative Site | Beaumont | Texas | 77702 | — |
| Investigative Site | Dallas | Texas | 75231 | — |
| Investigative Site | Denton | Texas | 76210 | — |
| Investigative Site | El Paso | Texas | 79935 | — |
| Investigative Site | Forney | Texas | 75126 | — |
| Investigative Site | Houston | Texas | 77017 | — |
| Investigative Site | Houston | Texas | 77024 | — |
| Investigative Site | Houston | Texas | 77058 | — |
| Investigative Site | Houston | Texas | 77090 | — |
| Investigative Site | Humble | Texas | 77338 | — |
| Investigative Site | Laredo | Texas | 78041 | — |
| Investigative Site | McAllen | Texas | 78504 | — |
| Investigative Site | Mesquite | Texas | 75149 | — |
| Investigative Site | Sugar Land | Texas | 77478 | — |
| Investigative Site | Kirkland | Washington | 98034 | — |
| Investigative Site | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04545060, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2022 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04545060 live on ClinicalTrials.gov.